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Abstract 
Background: For both men and women worldwide, colorectal cancer is among the leading causes of cancer-related 
death. This study aimed to assess the mortality trends of colorectal cancer in Serbia between 1991 and 2010, prior to 
the introduction of population-based screening.
Methods: Joinpoint regression analysis was used to estimate average annual percent change (AAPC) with the cor-
responding 95% confidence interval (CI). Furthermore, age-period-cohort analysis was performed to examine the 
effects of birth cohort and calendar period on the observed temporal trends.
Results: We observed a significantly increased trend in colorectal cancer mortality in Serbia during the study period 
(AAPC = 1.6%, 95% CI 1.3%–1.8%). Colorectal cancer showed an increased mortality trend in both men (AAPC = 2.0%, 
95% CI 1.7%–2.2%) and women (AAPC = 1.0%, 95% CI 0.6%–1.4%). The temporal trend of colorectal cancer mortality 
was significantly affected by birth cohort (P < 0.05), whereas the study period did not significantly affect the trend 
(P = 0.072). Colorectal cancer mortality increased for the first several birth cohorts in Serbia (from 1916 to 1955), fol-
lowed by downward flexion for people born after the 1960s. According to comparability test, overall mortality trends 
for colon cancer and rectal and anal cancer were not parallel (the final selected model rejected parallelism, P < 0.05).
Conclusions: We found that colorectal cancer mortality in Serbia increased considerably over the past two decades. 
Mortality increased particularly in men, but the trends were different according to age group and subsite. In Serbia, 
interventions to reduce colorectal cancer burden, especially the implementation of a national screening program, as 
well as treatment improvements and measures to encourage the adoption of a healthy lifestyle, are needed.
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Background
It is estimated that colorectal cancer causes over 600,000 
deaths worldwide annually, accounting for 7.6% of can-
cer-related deaths among men and 8.6% among women; 
this makes colorectal cancer the fourth most common 
cause of cancer-related death [1–3]. Although the num-
ber of deaths from colorectal cancer is almost the same 
in both developed and developing regions, the death 
rates vary by more than five times around the world [3]. 
According to the GLOBOCAN 2008 estimates, the high-
est colorectal cancer mortalities in both sexes were found 
in Central and Eastern Europe (20.3 per 100,000 for men, 
12.1 per 100,000 for women); the lowest mortalities in 
both sexes were found in Middle Africa (3.5 per 100,000 
and 2.7 per 100,000, respectively) [1–3].
During the last decade of the twentieth century, colo-
rectal cancer mortality declined steeply in more devel-
oped regions: western and northern European countries 
(the United Kingdom, France, and Sweden), countries 
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in North America (the United States of America and 
Canada), and Australia [3, 4]. At the beginning of the 
twenty-first century, declines were also observed in 
Japan, Germany, and Italy [5, 6]. In contrast, most coun-
tries in Eastern Europe (such as Russia and Romania) 
and Southern Europe (such as Portugal and Spain) saw 
a steep increase in colorectal cancer mortality; however, 
this was not the case in all countries (e.g., the Czech 
Republic, Hungary, and Slovakia) [3–5]. Trends were 
particularly favorable in young people (under 50 years of 
age), especially in young women [6]. The decreasing mor-
tality trend for colorectal cancer in developed countries 
after 1990 may be attributable to the implementation 
of screening programs and improvements in treatment 
[7, 8]. More recent screening programs implemented in 
some European countries probably have had some effect 
on colorectal cancer mortality [9, 10]; recent socio-eco-
nomic changes may have also had a role in reducing colo-
rectal cancer incidence and mortality [11].
Most patients who died of colorectal cancer were aged 
50  years or older [3, 6, 12]. Colorectal cancer mortality 
was 1–2 times higher for men than for women [6]. The 
etiology of colorectal cancer has not been entirely eluci-
dated, but older age, inflammatory bowel disease, fam-
ily history, dietary factors, obesity, low physical activity, 
alcohol consumption, and tobacco smoking have been 
recognized as risk factors for colorectal cancer [13, 14].
The purpose of this study was to assess temporal 
changes in colorectal cancer mortality in Serbia between 




Colorectal cancer was defined according to the Interna-
tional Classification of Diseases (ICD) as malignant neo-
plasm of the colon (ICD-9 code 153 and ICD-10 code 
C18) and malignant neoplasm of the rectum, rectosig-
moid junction, and  anus (ICD-9 code 154 and ICD-10 
codes C19–21). Mortality data were obtained from the 
Statistical Office of the Republic of Serbia (unpublished 
data). This analysis comprised the entire population of 
the Republic of Serbia (all ages), during the period 1991–
2010, excluding the Autonomous Province of Kosovo 
and Metohia, for which data have been unavailable since 
1998. Data on the population and composition of the 
Republic of Serbia (approximately 7.5 million people) by 
sex and age were obtained from the population censuses 
in 1991 and 2002; for inter-census years, estimates pub-
lished by the Statistical Office of the Republic of Serbia 
were used [15]. In Europe, Serbia had the largest num-
ber of internally displaced people and refugees (nearly 
400,000 people) during the period 1991–2010; these data 
were included in the Serbian population and could not be 
set aside as a special contingent. This study was approved 
by the Ethics Committee of the Faculty of Medical Sci-
ences, University of Kragujevac (protocol: 01-4801).
Statistical analysis
We calculated three types of death rates (per 100,000 
people): crude, age- and sex-specific, and age-standard-
ized. The age-standardized rate (ASR) was calculated 
by direct method (Segi’s world population was used as 
standard population, stratified by 10-year age groups) 
[16]. To obtain the number of deaths expected in the 
standard population, the specific rates that were observed 
in Serbia were applied on the standard population using 
direct method of standardization. The standardized rate 
in Serbia was calculated by dividing the expected number 
of deaths in the standard population by the total standard 
population. The rates, with number of cases, were given 
for the beginning and the end of the study period for sev-
eral age groups (30–34, 35–39, …, and 75–79).
Trends in colorectal cancer mortality were assessed 
using joinpoint regression analysis (Joinpoint Regression 
Software, Version 4.0.4—May 2013; Statistical Method-
ology and Applications Branch, Surveillance Research 
Program of the US National Cancer Institute; Bethesda, 
MD, USA) according to the method proposed by Kim 
et  al. [17]. Lerman’s Grid Search Method [18] was used 
to create a fine grid of all possible locations for joinpoints 
specified by the settings and to determine the sum of 
squared error at each one. The Grid Search Method was 
used to fit the segmented line regression where the join-
point estimates occur at discrete grid points and to deter-
mine the best fit for each individual model. The program 
started with a minimum of zero joinpoint and was tested 
to determine whether one or more joinpoints were statis-
tically significant (up to the maximum of five joinpoints 
that were allowed for each model). The Monte Carlo Per-
mutation method with 4499 replicates was used to test 
significance. Once the line segments were fortified, the 
annual percent change (APC) was used to describe the 
trends in the model. In ASRs of colorectal cancer mortal-
ity (1991–2010), trends are presented as average annual 
percentage changes (AAPCs), which are a summary 
measure over a fixed interval [19]. For each estimate of 
APC, 95% confidence intervals (CIs) were calculated and 
used to determine if the APC for each segment differed 
significantly from zero. Also, we assessed pairwise dif-
ferences using a comparability test to determine whether 
the two segmented line regression functions were parallel 
(test of parallelism) or whether the two mean functions 
were identical (test of coincidence) [20]. Two-sided P 
values less than 0.05 were considered statistically signifi-
cant. Joinpoint results were not shown for the subgroups 
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of deceased people younger than 30 years because fewer 
than five deaths from colorectal cancer occurred in each 
5-year age group in any year. We conducted separate 
analyses for cancer of the colon and the rectum and anus. 
We analyzed mortalities for men and women separately 
to account for sex-related differences in the natural his-
tory. Given the small number of deceased people younger 
than 30  years, we limited our analysis to those aged 
30–79.
Additionally, using the United States National Cancer 
Institute statistical web tool according to the method 
proposed by Rosenberg et al. [21], we conducted an age-
period-cohort analysis to examine the effects of birth 
cohort and calendar period on the observed tempo-
ral trends. For age-period-cohort analysis, we used the 
colorectal cancer mortality data stratified by 5-year age 
groups (30–34, 35–39, …, and 75–79); 5-year intervals 
were also used for calendar periods (1991–1995, 1996–
2000, …, and 2006–2010) and birth cohorts (1916–1920, 
1921–1925, …, and 1976–1980). The central age group, 
period, and birth cohort were defined as the reference. 
The  degrees of freedom counted the number of free 
parameters included in each test. The age-period-cohort 
analysis summarized the deviations from linearity for 
age, period, and cohort. A marked deviation from zero 
may indicate the presence of a cohort effect (nonlinearity 
of period and age effects). The age-period-cohort param-
eter, called the local drifts, is the APC (with two-tailed 
95% CIs) of the expected age-specific rates over time. 
APC analysis was used to estimate the net drift param-
eter, which represents the net sum of the log-linear tem-
poral trend arising from period effects and birth cohort 
effects. The 1-df Wald test was used to determine sig-
nificance. P values less than 0.05 were considered statisti-
cally significant.
Results
In Serbia during the period 1991–2010, nearly 42,000 
people died of colorectal cancer; the average annual ASR 
was 14.2 per 100,000 people (Table 1). The average ASR 
of colorectal cancer mortality was higher in men (18.3 
per 100,000) than in women (11.0 per 100,000).
During the study period, we observed a signifi-
cant trend of increase in colorectal cancer mortal-
ity (AAPC  =  1.6%, 95% CI 1.3%–1.8%; Fig.  1). The 
colorectal cancer mortality trend increased in both 
men (AAPC  =  2.0%, 95% CI 1.7%–2.2%) and women 
(AAPC =  1.0%, 95% CI 0.6%–1.4%; Fig. 2). The compa-
rability test showed that the colorectal cancer mortality 
trends in men and women were not parallel (the final 
selected model rejected parallelism, P < 0.05).
In our study, the ASRs of people aged 50 years and older 
were 10–25 times higher than those of people in younger 
age groups (Table 2). Trends in age-specific mortality for 
colorectal cancer showed a significant increase for people 
aged 50 years and older (by 1.6, 2.1, 1.8, 1.5, 1.6, and 1.9% 
per year, respectively), whereas for people in younger age 
groups, non-significant changes were observed. Joinpoint 
analysis did not identify any joinpoint for the trend in any 
age group.
Age-period-cohort analysis showed deviations from 
linearity for all three factors: age, period, and cohort 
(Table  3). These measures tended to distribute around 
approximately zero. A slight deviation from zero was 
observed for people born in the 1956–1960 cohort. In the 
Serbian population, the risk of death from colorectal can-
cer increased monotonically for people aged 30–79 years 
(Fig. 3). The local drift values were above zero in all of the 
oldest age groups (50–79  years), although a few insig-
nificant exceptions were observed in the youngest age 
groups (30–39  years). The period effects remained rela-
tively stable but were elevated in the most recent period 
(2001–2010). Colorectal cancer mortality increased for 
the first several birth cohorts, followed by downward 
flexion for people born after the 1960s. The local drifts 
were not statistically significant (Wald test  =  7.943, 
df  =  10, P  =  0.634). Wald tests showed statistically 
Table 1 Colorectal cancer mortality in  Serbia during  the 
period 1991–2010: number of deaths, crude rate, and age-
standardized rate (ASR)
a ASR was calculated by using Segi’s world standard population. All rates in this 
table are presented as the number of deaths per 100,000 people
Year No. of deaths Crude rate ASRa
1991 1478 19.5 11.9
1992 1619 21.3 12.7
1993 1621 21.3 12.6
1994 1646 21.6 12.4
1995 1724 22.6 12.7
1996 1858 24.4 13.6
1997 1903 25.0 13.8
1998 1969 26.0 13.9
1999 1950 25.9 13.6
2000 2072 27.6 14.2
2001 2004 26.7 13.6
2002 2180 29.1 14.6
2003 2147 28.7 14.2
2004 2282 30.6 14.9
2005 2485 33.4 16.1
2006 2422 32.7 15.5
2007 2402 32.5 15.0
2008 2560 34.8 16.1
2009 2649 36.2 16.4
2010 2573 35.2 15.9
Total 41,544 27.8 14.2
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significant cohort effects (P < 0.001) and non-significant 
period effects (P = 0.072).
During the period 1991–2010 in Serbia, in men, overall 
mortality of colon cancer has been significantly increas-
ing (by 2.6% per year), similar to that of rectal and anal 
cancer (by 1.4% per year), as shown in Tables  4 and 5. 
During the same period in Serbia, colon cancer mortality 
for women overall increased by 1.7% per year, but no 
significant changes for rectal and anal cancer mortality 
were observed (AAPC  =  0.2%). In people of either sex 
who were 50 years of age or older, a significant increase 
in colon cancer mortality was observed. For men aged 
50 years and above, rectal and anal cancer mortality sig-
nificantly increased. For women in all age groups, no 
Fig. 1 Trend in mortality of colorectal cancer in Serbia during the period 1991–2010: a joinpoint regression analysis. ^Statistically significant trend, 
APC average percentage change
Fig. 2 Trend in mortality of colorectal cancer in Serbia, by sex, during the period 1991–2010: a joinpoint regression analysis. ^Statistically significant 
trend, APC average percentage change
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significant changes for rectal and anal cancer mortality 
were observed. According to the comparability test, over-
all mortality trends for colon cancer and rectal and anal 
cancer were parallel (the final selected model failed reject 
parallelism, P = 0.279).
Discussion
The colorectal cancer mortality in Serbia increased con-
siderably over the past two decades. Mortality increased 
particularly in men, but the trends were different accord-
ing to age group and subsite. The increased colon cancer 
mortality among younger men is particularly worrisome. 
The exceptions were women, in whom no significant 
trend in rectal and anal cancer mortality was observed.
Worldwide in 2010, Hungary had the highest colorec-
tal cancer mortalities for both men and women (31.1 per 
100,000 men and 16.1 per 100,000 women); Georgia and 
Egypt had the lowest mortalities for both sexes (approxi-
mately 2.1 per 100,000 men and 1.6 per 100,000 women) 
[3]. Serbia was among the countries with high colorec-
tal cancer mortality; other countries with high mortal-
ity included the Russian Federation, Poland, Portugal, 
Slovenia, and the Czech Republic. Except in only a few 
countries (Kuwait, Cuba, and Qatar), the colorectal can-
cer mortality was higher for men than for women [3]. The 
large geographic differences in the global distribution of 
colorectal cancer are generally difficult to explain [6]. The 
high mortality across central and eastern European coun-
tries, as well as in Serbia and some Mediterranean coun-
tries, likely reflects fundamental changes that occurred 
during the transition period since the 1980s [22]. These 
Table 2 Joinpoint regression analysis of  colorectal cancer mortality in  Serbia (by age) during  the period 1991–2010, 
with data for the beginning and the end of the study period
AAPC average annual percentage change, CI confidence interval
a Joinpoint results are not shown for the subgroups of deceased people younger than 30 years because fewer than five colorectal cancer deaths occurred in each 
5-year age group in any year
b All the rates are presented as number of deaths per 100,000 people
c Statistically significant trend
Age (years)a Average annual  
age-specific rateb
Year 1991 Year 2010 AAPC 95% CI
No. of deaths Mortality b No. of deaths Mortality b
30–34 1.50 2 0.37 12 1.73 0.1 −4.3 to 4.8
35–39 2.84 31 4.85 16 3.25 −1.0 −2.8 to 0.9
40–44 6.28 36 6.19 33 6.96 0.3 −1.2 to 1.8
45–49 11.72 46 11.04 55 11.13 0.0 −1.2 to 1.3
50–54 20.70 87 16.93 128 24.13 1.6c 0.9 to 2.4
55–59 34.26 147 25.90 230 39.58 2.1c 1.6 to 2.7
60–64 56.88 223 42.40 286 61.34 1.8c 1.4 to 2.3
65–69 83.46 293 72.45 329 98.91 1.5c 1.1 to 1.9
70–74 120.96 190 96.10 451 128.23 1.6c 1.2 to 2.1
75–79 154.77 192 128.53 539 185.59 1.9c 1.4 to 2.4
Table 3 Age, period, and cohort effects on colorectal can-
cer mortality in Serbia during 1991–2010
Group Effect Deviation 95% Confidence interval
Age 30–34 −0.115 −0.410 to 0.180
35–39 −0.181 −0.412 to 0.051
40–44 0.011 −0.177 to 0.198
45–49 0.099 −0.057 to 0.255
50–54 0.115 −0.013 to 0.243
55–59 0.155 0.056 to 0.253
60–64 0.176 0.106 to 0.246
65–69 0.068 0.012 to 0.124
70–74 −0.048 −0.116 to 0.021
75–79 −0.280 −0.380 to −0.180
Period 1991–1995 −0.009 −0.036 to 0.018
1996–2000 0.017 −0.024 to 0.059
2001–2005 −0.009 −0.047 to 0.029
2006–2010 0.000 −0.026 to 0.026
Cohort 1916–1920 −0.169 −0.367 to 0.029
1921–1925 −0.095 −0.216 to 0.027
1926–1930 −0.063 −0.146 to 0.020
1931–1935 −0.043 −0.101 to 0.014
1936–1940 0.001 −0.058 to 0.060
1941–1945 0.043 −0.038 to 0.125
1946–1950 0.063 −0.045 to 0.172
1951–1955 0.123 −0.006 to 0.252
1956–1960 0.196 0.043 to 0.348
1961–1965 −0.039 −0.228 to 0.150
1966–1970 −0.002 −0.261 to 0.256
1971–1975 −0.162 −0.572 to 0.248
1976–1980 −0.499 −1.290 to 0.292
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high mortalities are most likely the result of increased 
risk factors associated with “westernization,” such as 
increased animal fat and red meat consumption, low 
vegetable intake, obesity, physical inactivity, tobacco use, 
and alcohol consumption, which, in the past few decades, 
characterized newly economically developed countries 
[5, 10]. In our study, we found that colorectal cancer mor-
tality increased markedly with age in the cohort of people 
born between 1956 and 1960. This finding must be inter-
preted carefully, though, because these cohort values are 
based on fewer deaths (i.e., lower ASRs). However, since 
trends in birth cohort effects usually reflect risk factor 
trends, this increase seems to indicate an increasing colo-
rectal cancer risk in this cohort. During this 1991–2010 
period (after the separation from the Eastern Bloc), Ser-
bia sought to accelerate economic development, urbani-
zation, and industrialization, which led to changes in 
lifestyle and dietary structure. Social circumstances in 
Serbia were further affected by a devastating economic 
crisis, which was exacerbated by United Nations sanc-
tions, civil wars in the former Yugoslavia (1991–1995), 
hundreds of thousands of refugees, the collapse of the 
dinar, the inability to purchase needed medications, the 
deterioration of public health, and the bombing of Serbia 
(1999), as well as post-2000 changes during democrati-
zation [23, 24]. In addition, the mortality partly reflects 
varying data quality worldwide [25].
During the last decade, the colorectal cancer mortali-
ties for both men and women annually declined in the 
United States (by 2.9% per year for all races) [4] and in 
most countries of Western and Northern Europe (in Ger-
many by 2.0%, France by 1.7%, and the United Kingdom 
and Italy by 1.5% per year) [5]. Conversely, the colorectal 
cancer mortalities for both men and women have shown 
a continuous annual rise over the last decade in some 
Eastern and Central European countries, such as Russia 
(by 0.6% per year) and Croatia and Serbia (by 1.6% per 
year) [5, 26]. Also, increased trends have been observed 
Fig. 3 Mortality of colorectal cancer in Serbia during the period 1991–2010: an age-period-cohort analysis. a Longitudinal age curves of colorectal 
cancer mortalities: longitudinal age curves of the mortalities (per 100,000 people) of colorectal cancer and the corresponding 95% confidence 
intervals (the area colored in pink). b Local drift values for colorectal cancer mortalities: age group-specific annual percent change (%) in the mortali-
ties of colorectal cancer and the corresponding 95% confidence intervals (the area colored in grey). c Period effects on colorectal cancer mortalities: 
period effects obtained from age-period-cohort analyses for the mortalities of colorectal cancer and the corresponding 95% confidence intervals 
(the area colored in blue). d Cohort effects on colorectal cancer mortalities: cohort effects obtained from age-period-cohort analyses for the mortali-
ties of colorectal cancer and the corresponding 95% confidence intervals (the area colored in green)
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in some Central and South American countries (e.g., 
Mexico and Brazil) [27]. On the other hand, in Slova-
kia and Slovenia the colorectal cancer mortalities were 
very high, but they remained constant for both men and 
women in the last decade [6]. In most countries, colorec-
tal cancer mortality trends for both men and women were 
more favorable in young people (aged under 50 years) [6]. 
In Spain, Poland, and Hungary, during the period 1970–
2007, particularly favorable colorectal cancer mortality 
trends were observed in women in all age groups com-
pared to men [6]. The decrease in colorectal cancer mor-
tality in the United States and Western Europe (e.g., the 
United Kingdom and France) could be attributed to long-
term screening programs and improvements in treatment 
protocols, as well as to positive lifestyle changes [7–9]. In 
some Eastern European countries, the benefits, however, 
of short-term colorectal cancer screening, improvements 
in treatment, and recent positive changes in dietary and 
lifestyle habits are still only estimated [9–11, 28]. The 
promising colorectal cancer mortality trends in women 
and young people may reflect recent positive changes in 
diet and lifestyle habits (such as reduced alcohol drinking 
and tobacco smoking), which have been recommended as 
cancer prevention measures [11, 29].
In Serbia, the lack of decline in colorectal cancer mor-
tality indicates suboptimal levels of cancer control. In 
2013, a national program for the early detection of colo-
rectal cancer was implemented. Countrywide data are 
not yet available, but a single-institution analysis found 
that the 5-year overall survival rate was 57.8% in patients 
younger than 40 and 28.5% in patients over 65  years of 
age [30]. For patients with colorectal cancer in Europe, 
EUROCARE-4 study investigators reported a 5-year 
relative survival rate of 53.8%; in this study, the highest 
survival rates were observed in the Nordic and Central 
European countries, and the lowest survival rates were 
observed in Eastern Europe [31]. In central Serbia during 
the period 1999–2008, colorectal cancer  incidence was 
high and showed an increasing trend [22, 25]. The analy-
sis of disease burden in Serbia showed that, for colorec-
tal cancer, the harmful effects of physical inactivity were 
higher in women than in men (31.0% vs. 20.6% of total 
Table 4 Number of deaths, crude and ASR of colorectal cancer mortality for men and women in Serbia during the period 
1991–2010
a ASR was calculated by using Segi’s world standard population. All rates in this table are presented as the number of deaths per 100,000 people
Year Men Women


















1991 370 10.0 6.9 452 12.2 8.2 314 8.1 4.4 342 8.8 4.9
1992 414 11.1 7.4 483 13.0 8.5 348 9.0 4.9 374 9.6 5.4
1993 390 10.5 6.9 467 12.6 8.3 403 10.4 5.6 361 9.3 4.9
1994 408 11.0 7.1 489 13.1 8.3 377 9.7 5.0 372 9.5 5.1
1995 430 11.5 7.2 525 14.1 8.9 383 9.8 5.0 386 9.9 5.1
1996 471 12.7 7.8 551 14.8 9.0 396 10.2 5.3 440 11.3 5.9
1997 495 13.3 8.1 560 15.1 9.2 451 11.6 5.9 397 10.2 5.2
1998 530 14.4 8.6 550 14.9 8.8 448 11.5 5.7 441 11.4 5.5
1999 526 14.3 8.2 603 16.4 9.6 432 11.2 5.5 389 10.0 4.8
2000 564 15.4 8.9 638 17.5 9.8 424 11.0 5.0 446 11.6 5.5
2001 556 15.2 8.7 606 16.6 9.2 411 10.7 5.0 431 11.2 5.2
2002 626 17.2 9.8 639 17.5 9.6 477 12.4 5.5 438 11.4 5.2
2003 564 15.5 8.5 617 17.0 9.4 470 12.2 5.5 496 12.9 5.9
2004 660 18.2 9.8 651 17.9 9.8 543 14.2 6.2 428 11.2 5.0
2005 688 19.0 10.2 719 19.9 10.8 601 15.7 6.8 477 12.5 5.6
2006 696 19.3 10.2 675 18.7 9.8 562 14.8 6.5 489 12.8 5.5
2007 719 20.0 10.1 673 18.8 9.8 535 14.1 6.1 475 12.5 5.1
2008 784 21.9 11.1 680 19.0 9.8 608 16.1 6.9 488 12.9 5.4
2009 781 21.9 10.8 774 21.7 11.1 615 16.4 6.6 479 12.7 5.4
2010 753 21.2 10.6 778 21.9 11.0 565 15.1 6.1 477 12.7 5.2
Overall 11,425 15.7 8.8 12,130 16.6 9.4 9363 12.2 5.7 8626 11.2 5.3
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disability-adjusted life years [DALY]), as were the harm-
ful effects of being overweight (16.3% vs. 13.1% of total 
DALY) [32]. The 2006 National Health Survey found that, 
in Serbia, 54.5 % of people were overweight, subdivided 
as 18.3% obese and 36.2% pre-obese [33]. This survey also 
found that the average body mass index (BMI) of Serbi-
ans older than 20 years was 26.7 kg/m2 (27.4 for men and 
26.0 for women); this represented a substantial increase 
over 2000, when the average BMI was 26.0. In 2006, 
nearly one-third of the employed population of Serbia 
(31.1%) had a sedentary type of work; this, too, repre-
sented a substantial increase over 2000, when the figure 
was only 25.2%. Also, more than two-thirds of Serbian 
people (67.7%) spent their free time mainly in a sedentary 
manner. In 2006 in Serbia, smoking was more prevalent 
in men (38.1%) than in women (29.9%). On average, men 
drank four times more alcohol than women (8.5 vs. 2.0 
drinks per week) [33]. Similarly, in 30 European coun-
tries, the level of exposure to underlying lifestyle cancer 
risk factors corresponds to the pattern of cancer inci-
dence [34]. In the present study, different time trends in 
mortality for both sexes and for subsites in the Serbian 
population suggest that colorectal cancer has, at least in 
part, different etiological factors. Furthermore, the possi-
bility that proximal colon cancers differ from distal colon 
cancers in terms of biology or carcinogenesis could be an 
explanation for some variations between countries in the 
epidemiological and clinical peculiarities of colorectal 
cancer, as well as differences in cancer detection, treat-
ment, and survival [35, 36].
A strength of our study is that it provides the first 
nationwide estimates of colorectal cancer mortality in 
Serbia in last two decades. Another strength is that it is 
a population-based study that used high-quality cancer 
data with temporal trends analyzed by both joinpoint 
and age-period-cohort analysis. Also, this high-quality 
data (including a comprehensive, countrywide death reg-
istration system in Serbia) enabled us to make compari-
sons with other countries [25, 37]. Regarding causes of 
death in Serbia, the World Health Organization (WHO) 
assessed the quality of data as moderate [37]. For exam-
ple, for the most recent year (2012), the percentage of 
unknown and ill-defined cancer deaths in Serbia was 
3.8%, which the WHO considered as moderate quality 
[25]. Contrary to the trends in many countries, the colo-
rectal cancer mortality in Serbia is increasing. Because 
of this rising mortality trend in Serbia, more effective 
cancer prevention measures (such as measures focusing 
on diet and the control of healthy weight, tobacco use, 
and alcohol consumption), more effective treatments for 
colorectal cancer, and more effective cancer screening 
programs focusing on early diagnosis are needed.
Our study did have several limitations. First, we 
acknowledge that a longer study period may have ena-
bled us to better assess mortality trends, but in Serbia 
no data were available for this. Second, no separate data 
exist on colorectal cancer deaths among refugees that 
can possibly confound the colorectal cancer pattern in 
Serbia. Clearly, a higher-quality death registration sys-
tem, which is available in wealthier countries, is needed 
in Serbia. Third, during the study period, two different 
revisions of the ICD were used for cancer coding. Fourth, 
no data are available on colorectal cancer incidence for 
the entire Republic of Serbia, which limited our ability to 
explain the increasing mortality trends. Fifth, we had no 
reliable data on colorectal cancer therapy in Serbia dur-
ing the study period. The available literature does not 
have enough relevant information concerning colorectal 
Table 5 Joinpoint regression analysis of age-specific mor-
tality rates of  colorectal cancer in  Serbia, by  sex, in  the 
period 1991–2010
AAPC average annual percentage change, CI confidence interval
a  Joinpoint results are not shown for the subgroups of deceased people 
younger than 30 years, because fewer than five colorectal cancer deaths 
occurred in each 5-year age group in any year
b Joinpoint analysis was not possible, because there were no colorectal cancer 
deaths in at least one year during the observed period
c Statistically significant trend
Agea Colon cancer Rectal and anal cancer
AAPC 95% CI AAPC 95% CI
Men
 30–34 –b –b –b –b
 35–39 –b –b −3.3 −8.5 to 2.1
 40–44 2.7c 0.3 to 5.1 −1.2 −4.5 to 2.3
 45–49 −1.2 −3.5 to 1.2 0.6 −1.0 to 2.3
 50–54 2.8c 1.4 to 4.3 1.5 −0.2 to 3.2
 55–59 3.1c 2.1 to 4.1 2.1c 1.2 to 3.1
 60–64 3.1c 2.1 to 4.2 2.0c 1.3 to 2.7
 65–69 2.5c 1.7 to 3.3 1.5c 0.7 to 2.2
 70–74 2.9c 2.0 to 3.8 0.7 −0.1 to 1.4
 75–79 2.9c 1.9 to 3.8 1.8c 0.6 to 3.0
All men 2.6c 2.2 to 3.0 1.4c 1.1 to 1.7
Women
 30–34 –b –b –b –b
 35–39 1.7 −2.4 to 6.0 –b –b
 40–44 −0.8 −4.2 to 2.7 −0.1 −3.0 to 2.9
 45–49 −0.2 −2.3 to 1.8 1.2 −1.6 to 4.0
 50–54 2.3c 0.4 to 4.3 0.1 −1.9 to 2.2
 55–59 2.4c 0.5 to 4.4 0.3 −0.8 to 1.4
 60–64 2.2c 1.3 to 3.1 −0.7 −1.9 to 0.5
 65–69 1.4c 0.5 to 2.4 −0.1 −0.8 to 0.7
 70–74 1.6c 0.8 to 2.5 0.6 −0.2 to 1.5
 75–79 1.7c 0.8 to 2.7 1.0 −0.1 to 2.2
All women 1.7c 1.1 to 2.3 0.2 −0.2 to 0.7
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cancer risk factors in the Serbian population. Fecal occult 
blood testing has been recommended as a national colo-
rectal cancer screening test since only 2013. Therefore, 
the incompleteness of colorectal cancer screening data in 
Serbia, which could be used to explain mortality trends, 
is a limitation of our study. Future studies should investi-
gate whether patterns of risk factors are present in some 
age cohorts. The colorectal cancer mortality in Serbia 
contributes to its ranking among countries with the high-
est mortality. Increasing trends in the colorectal cancer 
mortality indicate that improved primary and secondary 
prevention measures, which target young men, particu-
larly, are needed. Reduction in the burden of colorectal 
cancer in Serbia will require the implementation of a 
comprehensive national screening program.
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